openPR Logo
Press release

Anterior Uveitis Market to Perceive Substantial Growth by 2024

03-13-2018 01:38 PM CET | Health & Medicine

Press release from: Transparency Market Research

Anterior Uveitis Market to Perceive Substantial Growth by 2024

Uveitis is the inflammation of the uveal region of the eye, most commonly by an infection. Uvea is a group of pigmented and non pigmented tissues lying in the middle among the three layers that make the eye. Uvea again consists of three layers: iris, cilliary body and the choroid. The uvea is also known as the uveal tract in some medical circles, this tract is necessary for the nutrition of the eye and also to reduce glare of the light that enters by absorbing the light and reducing internal reflection within the eye. In addition the uvea also helps in generating the aqueous humour and in controlling the focus of the eye lens. The uvea also consists of lymphocytes and is therefore prone to respond to inflammation by developing lymphocytic infiltrates. Uveitis is therefore a condition that requires urgent response from an ophthalmologist and immediate treatment.

Anterior Uveitis mainly includes iritis, which is known as the inflammation of the anterior chamber and the iris, and iridocyclitis, which is inflammation of the iris anterior chamber and the vitreous cavity. Anterior uveitis presents itself as redness of the eyes, irregular pupils, photophobia, blurred vision, eye pain/pressure, floaters visible to the patient, headaches, iridocyclitis induced cataract/glaucoma or synechia (attachment of iris to cornea or lens). The causative factors for uveitis has not yet been confirmed, however in half of the anterior uveitis cases a correlation was observed with the presence of HLA-B27 gene, which is a type of human leukocyte antigen (HLA) that increases the probability of an individual to contract uveitis by 15%.

Request to View Brochure of Report -

https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=2956

Anterior uveitis or acute anterior uveitis is the most common form of uveitis. Uveitis is primarily found to be systemic immune based; however possible causative factors in many cases also include infections from: Brucellosis, Leptospirosis, Lyme disease, Tuberculosis, Syphilis, Toxoplasmic chorioretinitis, Toxocariasis, or ocular histoplasmosis syndrome. Besides these drug interactions like rifabutin can also cause uveitis. Basically Uveitis occurs from the failed or hyperactive ocular immune response, this results in tissue destruction and inflammation, followed by buildup of mucus in extreme cases, hence the increased pressure.

The treatment for uveitis is mainly symptom specific, with steroids and non-steroidal anti inflammatory drugs ins the form of eye drops, or oral medications. Corneal ulcers if present may pose as complications hence anti-inflammatory medication is prescribed only after ruling out this disorder. Cyclopegics or ciliary muscle relaxants are administered for diagnosis or certain surgical treatment if necessary. Anti TNF agents and other anti metabolite medications may prove helpful in cases of severe uveitis, e.g. infliximab.

Request to View ToC of Report -

https://www.transparencymarketresearch.com/sample/sample.php?flag=T&rep_id=2956

Certain drugs like metformin, which is generally used as anti-diabetic drug has also been found to reduce inflammation in uveitis. Recent drugs like gevokizumab have undergone trials to for uveitis without infectious origin. The treatments given vary with the causative factor of uveitis, but overall the condition usually recedes after proper care and procedures are followed. In severe adverse cases, vision loss or cataract/glaucoma may occur, such cases however occur in very rare occasions. The incidence rate is as high as one in 4500 individuals globally according to a medical journal on ocular immunology. The incidence rates in developed countries of the west are higher than the developing countries in Asia and Africa. The anterior uveitis market is therefore restricted to North American and European region, followed by Asia, South America and Rest of the World.

Some of the companies involved in the production of uveitis related drugs include: Novartis AG, Amdipharm Mercury Company Limited, Santen pharmaceuticals, etc.

View Report -

https://www.transparencymarketresearch.com/anterior-uveitis-market.html

About Us

Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants, use proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.

US Office Contact
90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Anterior Uveitis Market to Perceive Substantial Growth by 2024 here

News-ID: 976750 • Views: 185

More Releases from Transparency Market Research

Modernization and Technological Upgrades to Invite Expansive Growth Opportunitie …
The airport runway FOD systems market is anticipated to grow at a promising CAGR across the assessment period of 2019-2027 on the back of the rising incidents of aircraft damage due to foreign objects on the runway. This is a grave problem that needs to be addressed by every airport across the globe. According to Boeing, foreign object debris (FOD) accounts for US$4 bn in damage to engines and aircraft
Market Intelligence Report on Calcite Market, 2018-2028
Sales of calcite have witnessed utter proliferation in recent time, in line with the growing demand from paper and pulp sector wherein calcite is highly adopted as a coating and filler material. According to Transparency Market Research analysis, global calcite market is anticipated to register 4.7% CAGR during the study period 2018–2028. The TMR report opines that demand for calcite is highly driven by its significant properties that are paving way
Pearlescent Pigments Market Intelligence Report Offers Growth Prospects
The demand within the global pearlescent pigment market is slated to rise as new creative avenues emerge in the art and craft industry. Several artists have increased the consumption of pearlescent pigments, mainly due to the aesthetic value of these pigments in art forms. The use of these pigments can majorly be attributed to the gloss and shine imparted by these pigments to the design or craft. These pigments exhibit
Aragonite Market to Witness Steady Growth During the Forecast Period 2018-2026
Global Aragonite Market: Overview Aragonite is a carbonate mineral having an orthorhombic crystal system, and very closely resembles calcite. It is considered as the purest form of calcium carbonate. The mineral has garnered wide popularity as gemstone in various parts of the world and has promising healing properties with energy enhancing powers. Aragonite contains traces of magnesium and sand inclusion but rich in calcium carbonate, and is alkaline in nature. It

All 5 Releases


More Releases for Uveitis

Uveitis Treatment Market: Global Market Of Uveitis Disease Is Estimated To Reach …
Uveitis Treatment Market Precision Business Insights (PBI) in its report titled “Global Uveitis Treatment Market: Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2012-2017 and Forecast 2018-2027” assesses the market performance over 2018-2027. The report analyses the market value forecast and provides the strategic insights into the market driving factors, challenges that are hindering the market revenue growth over forecast period. Uveitis is swelling of the middle layer of the eye,
Uveitis Therapeutic and Disease Pipeline Review H1
Summary Uveitis is swelling and irritation of the uvea, the middle layer of the eye. Uveitis can affect one or both eyes. Uveitis can be caused by autoimmune disorders such as rheumatoid arthritis or ankylosing spondylitis, infection, or exposure to toxins. Symptoms include blurred vision, dark, floating spots in the vision, eye pain, redness of the eye and sensitivity to light. The predisposing factors include having an infection, an autoimmune or
Uveitis Market 2018 Global Analysis, Opportunities and Forecast to 2026
Summary Uveitis is an inflammatory condition of the eye affecting mainly the uvea. It encompasses a heterogeneous collection of disorders characterized by ocular inflammation. Currently, there is only a limited number of approved drugs for the treatment of uveitis. Based on the diverse nature of uveitis , there is a high unmet need for varied therapy approaches. Significant efforts are being made to develop new treatments for uveitis, as current pharmacologic
Anterior Uveitis Market: An Industry Case Study
Uveitis is the inflammation of the uveal region of the eye, most commonly by an infection. Uvea is a group of pigmented and non pigmented tissues lying in the middle among the three layers that make the eye. Uvea again consists of three layers: iris, cilliary body and the choroid. The uvea is also known as the uveal tract in some medical circles, this tract is necessary for the nutrition
Global Uveitis Treatment Industry : Market Development, Analysis and Overview 20 …
Researchmoz added Most up-to-date research on "Global Market Study on Uveitis Treatment: Europe Market Projected to Represent Market Attractiveness Index of 1.3" to its huge collection of research reports. Persistence Market Research presents a comprehensive study of the global uveitis treatment market in a new publication titled Uveitis Treatment Market: Global Industry Analysis and Forecast, 20162024. The report forecasts the performance of the global uveitis treatment market across different geographical locations and
Uveitis Treatment Market By Indication (Anterior uveitis, Intermediate uveitis, …
Uveitis is a combined condition of inflammation and swelling of the eyes. Uvea comprises of three parts Iris, ciliary body (small ring shape muscles behind iris and choroid), and choroid (it is the layer of tissue between retina and sclera), which decides eye color and helps eye in focusing and absorbing light. Uveitis can be caused by eye problems, autoimmune disease, HIV, multiple sclerosis, reactive arthritis, Kawasaki disease tuberculosis, and